We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
1441 Studies found for: ( "January 30, 2012" : MAX ) [FIRST-RECEIVED-DATE] AND (lymphoma OR CLL [CONDITION ]) AND NOT myeloma [CONDITION] | Recruiting, Not yet recruiting, Available Studies
Applied Filters:

Terms and Synonyms Searched:

Terms Search Results* Entire Database**
Synonyms
lymphoma 1,384 studies 6,196 studies
Lymphomatous 3 studies 17 studies
Lymphosarcoma -- 1 studies
CLL 169 studies 1,515 studies
Chronic lymphocytic leukemia 129 studies 1,159 studies
Lymphocytic Lymphoma 49 studies 740 studies
b cell leukemia 12 studies 24 studies
Chronic lymphoid leukemia 1 studies 7 studies
B-Cell Lymphocytic Leukemia -- 1 studies
Chronic B-Lymphocytic Leukemia -- 1 studies
Chronic lymphatic leukemia -- 2 studies
Chronic Lymphoblastic Leukemia -- 1 studies
leukemia chronic lymphocytic -- 1 studies
Leukemia lymphocytic chronic -- 3 studies
Small Cell Lymphoma -- 1 studies
myeloma -- 2,250 studies
Kahler disease -- 4 studies
Myelomatosis -- 3 studies
plasma cell neoplasm -- 335 studies

   
-- No studies found
* Number of studies in the search results containing the term or synonym
** Number of studies in the entire database containing the term or synonym

Related Terms:

Click on a related term to refine your search.
This will narrow your search by adding an additional search term.
If your search becomes too narrow (finds too few studies), broaden it by removing search terms with the Modify Search page.

B B-Cell
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
Lymphoma, B-Cell
Brentuximab
Brentuximab Vedotin
C CD19
CD20
Cell
B-Cell
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
Lymphoma, B-Cell
cell lymphoma
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
mantle cell lymphoma
Peripheral T-cell Lymphoma
T-cell Lymphoma
Peripheral T-cell Lymphoma
Lymphoma, B-Cell
mantle cell lymphoma
Peripheral T-cell Lymphoma
T-cell
Peripheral T-cell Lymphoma
T-cell Lymphoma
Peripheral T-cell Lymphoma
Classical Hodgkin Lymphoma
cycle
D diffuse
Diffuse Large B-Cell Lymphoma
DLBCL
E Etoposide
F follicular
follicular lymphoma
H Histologic
Histologic Type
Neoplasms by Histologic Type
Hodgkin lymphoma
Classical Hodgkin Lymphoma
Non-Hodgkin's Lymphoma
I Ibrutinib
Immunoproliferative Disorders
L large
Diffuse Large B-Cell Lymphoma
Lymphatic
Lymphatic Diseases
Lymphoma
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
cell lymphoma
B-cell lymphoma
Diffuse Large B-Cell Lymphoma
mantle cell lymphoma
Peripheral T-cell Lymphoma
T-cell Lymphoma
Peripheral T-cell Lymphoma
Classical Hodgkin Lymphoma
Diffuse Large B-Cell Lymphoma
follicular lymphoma
Hodgkin lymphoma
Classical Hodgkin Lymphoma
Non-Hodgkin's Lymphoma
Lymphoma, B-Cell
Lymphoma, Non-Hodgkin
mantle cell lymphoma
Non-Hodgkin's Lymphoma
Peripheral T-cell Lymphoma
T-cell Lymphoma
Peripheral T-cell Lymphoma
Lymphoproliferative Disorders
M mantle
mantle cell lymphoma
N Neoplasms
Neoplasms by Histologic Type
NHL
Non-
Lymphoma, Non-Hodgkin
Non-Hodgkin's Lymphoma
O Obinutuzumab
Overall
Overall Response
P Peripheral T-cell Lymphoma
progression
Progression Free Survival
R Refractory
Relapsed
response
Overall Response
response rate
Rituximab
S survival
Progression Free Survival
T T-cell
Peripheral T-cell Lymphoma
T-cell Lymphoma
Peripheral T-cell Lymphoma
V vedotin
Brentuximab Vedotin